TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/30/22 16:58 | 12/28/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Mileson Glenna | WA | O | CFO | P | 142 | 2.85 | 0 | 50 | 45 | 160 | D | |||||||||||||||
6/24/22 19:53 | 6/23/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Mileson Glenna | WA | O | CFO | S | -7 | 2.69 | 0 | -3 | -2 | 109 | D | |||||||||||||||
4/12/22 19:36 | 4/11/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Mileson Glenna | WA | O | CFO | M.d | 32 | 10.64 | 0 | 3 | 3 | 100 | D | |||||||||||||||
1/6/22 17:08 | 1/4/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Mileson Glenna | WA | O | CFO | M.d | 9 | 1.35 | 0 | 6 | 7 | 97 | D | |||||||||||||||
6/10/21 18:48 | 6/10/21 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Mileson Glenna | WA | O | CFO | M.d | 9 | 1.35 | 0 | 6 | 8 | 90 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |